LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 53.77 | 84.90 | 279 | 6252 | 0.0446 | 0.2115 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 53.77 | 84.90 | 4879 | 6252 | 0.7803 | 0.9216 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 53.77 | 84.90 | 564 | 6252 | 0.0902 | 0.3570 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 53.77 | 84.90 | 6532 | 6252 | 1.0447 | 1.0141 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 55.48 | 84.90 | 303 | 6567 | 0.0461 | 0.2248 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 55.48 | 84.90 | 5131 | 6567 | 0.7812 | 0.9228 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 55.48 | 84.90 | 590 | 6567 | 0.0898 | 0.3621 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 55.48 | 84.90 | 6905 | 6567 | 1.0513 | 1.0160 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 57.18 | 84.90 | 343 | 6963 | 0.0493 | 0.2456 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 57.18 | 84.90 | 5409 | 6963 | 0.7768 | 0.9221 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 57.18 | 84.90 | 534 | 6963 | 0.0767 | 0.3354 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 57.18 | 84.90 | 7288 | 6963 | 1.0466 | 1.0144 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 58.88 | 84.90 | 366 | 7291 | 0.0502 | 0.2554 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 58.88 | 84.90 | 5676 | 7291 | 0.7784 | 0.9235 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 58.88 | 84.90 | 576 | 7291 | 0.0790 | 0.3472 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 58.88 | 84.90 | 7534 | 7291 | 1.0332 | 1.0102 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 60.59 | 84.90 | 380 | 7641 | 0.0497 | 0.2597 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 60.59 | 84.90 | 5895 | 7641 | 0.7714 | 0.9216 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 60.59 | 84.90 | 554 | 7641 | 0.0725 | 0.3350 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 60.59 | 84.90 | 7848 | 7641 | 1.0270 | 1.0082 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 62.29 | 84.90 | 396 | 7934 | 0.0499 | 0.2652 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 62.29 | 84.90 | 6094 | 7934 | 0.7680 | 0.9210 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 62.29 | 84.90 | 495 | 7934 | 0.0624 | 0.3091 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 62.29 | 84.90 | 8190 | 7934 | 1.0322 | 1.0097 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 63.99 | 84.90 | 397 | 8212 | 0.0483 | 0.2635 | MN20160318_Q02 | E19 |